;

3.00 EUR

Opening hours: 09:00 - 17:30 (Central European Standard Time: 12/24/2024 5:04:16 PM)
Exchange open, closes in 25 minutes
3.00 EUR (3.00%)
7.85 EUR (7.85%)
22.16 EUR (22.16%)
17.50 EUR (17.50%)
-14.46 EUR (-14.46%)
-44.53 EUR (-44.53%)
133.69 EUR (133.69%)
-95.57 EUR (-95.57%)

About Pharming Group N.V.

Market Capitalization 597.29M

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.

Headquarters (address)

Darwinweg 24

Leiden 2333 CR

Netherlands

Phone31 71 524 7400
Websitehttps://www.pharming.com
Employees382
SectorHealthcare
IndustryBiotechnology
TickerPHARM
ExchangeEuropean Stock Exchange
CurrencyEUR
52 week range3.00 - 1.22
Market Capitalization597.29M
P/E trailing57.15
P/E forward-88.05
Price/Sale2.09
Price/Book2.01
Beta3.00
EPS5.00
EPS Netherlands (ID:23, base:88) 1.55

CleverShares.com|
2024 ©

1.0.9119.29486